BMY vs SEVN · P/E 17, rev $24.46B vs P/E 9.5, rev $29.4M
Bristol-Myers Squibb Company (BMY) versus Seven Hills Realty Trust (SEVN) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Seven Hills Realty Trust (SEVN) is a reit - mortgage company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported SEVN revenue for 2025-12-31 was $29.4M. Net income was $15.4M. Revenue was down 16.7% from 2024-12-31 to 2025-12-31. SEVN currently screens at market cap $193.0M and trailing P/E 9.5.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. SEVN currently screens at market cap $193.0M and trailing P/E 9.5.
Not investment advice. Open the BMY and SEVN stock pages for the full models.
Not investment advice.